Market and competition in healthcare, the case of Daraprim: faster, cheaper and more efficient than government tariffs

http://www.sandiegouniontribune.com/news/2015/oct/22/imprimis-turing-daraprim/

http://theweek.com/articles/583337/brief-guide-big-pharma?google_editors_picks=true

http://www.fiercepharma.com/story/imprimis-targets-another-shkreli-price-hike-compounded-rival-30-pill-thiola/2016-02-11

https://www.currentaffairs.org/2016/02/all-of-your-attempts-to-redeem-martin-shkreli-will-fail